Dolan v. Teva Pharmaceuticals, USA, Inc., et al
Consolidated
Lead case: 1:20-md-02974
Lead case: 1:20-md-02974
| Georgia Northern District Court | |
| Judge: | Leigh Martin May |
| Case #: | 1:21-cv-03871 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1332 Diversity-Personal Injury |
| Case Filed: | Sep 20, 2021 |
| Terminated: | Sep 30, 2021 |
| Case in other court: | California Northern, 3:21-cv-06796 |
| Last checked: Saturday Mar 19, 2022 6:01 AM EDT |
|
Defendant
Coopersurgical Inc
|
Represented By
|
|
Defendant
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
|
Represented By
|
|
Defendant
Teva Pharmaceuticals USA Inc
|
Represented By
|
|
Defendant
Teva Women's Health Inc
|
Represented By
|
|
Defendant
Teva Women's Health LLC
|
Represented By
|
|
Defendant
The Cooper Companies Inc
|
Represented By
|
|
Plaintiff
Janice Dolan
|
Represented By
|
GPO
Sep 20 2021
CONDITIONAL TRANSFER ORDER (CTO-34) transferring case to Northern District of Georgia, In Re: Paragard IUD Products Liability Litigation MDL No. 2974. (gbaS, COURT STAFF) (Filed on 9/20/2021) [Transferred from California Northern on 9/20/2021.] |
| Docket last updated: 01/26/2025 11:59 PM EST |
| Friday, November 15, 2024 | ||
| 20 | 20
2
pgs
order
Order on Motion to Appoint Counsel
Mon 11/18 3:55 PM
ORDER: Defendants' Consent Motion to Revise Leadership Structure for MDL Proceedings, Doc. No. 731 , is GRANTED. Therefore, the Clerk is directed to substitute Kasey M. Adams, Esq., for Tara L. Blake, Esq., as Co-Lead Counsel for the Cooper Defendants in this action and in all associated cases. Signed by Judge Leigh Martin May on 11/15/2024. Associated Cases: 1:20-md-02974-LMM et al.(tht) |
|
| 19 | 19
1
pgs
order
Order on Motion to Withdraw as Attorney
Mon 11/18 12:41 PM
ORDER granting (730 in 1:20-md-02974-LMM) Tara L. Blake's unopposed motion to withdraw as counsel of record for Defendants CooperSurgical, Inc. and The Cooper Companies, Inc. Signed by Judge Leigh Martin May on 11/15/2024. Associated Cases: 1:20-md-02974-LMM et al. (bgt) |
|
| Friday, January 27, 2023 | ||
| 18 | 18
1
pgs
order
Order Allowing Audio/Visual Equipment in the Courtroom
Fri 01/27 9:23 AM
ORDER ALLOWING AUDIO/VISUAL EQUIPMENT IN THE COURTROOM on January 20, 2023 and January 31, 2023 at 10:00 a.m. Signed by Judge Leigh Martin May on 1/27/2023. Associated Cases: 1:20-md-02974-LMM et al.(jra) |
|
| Tuesday, January 17, 2023 | ||
| 17 | 17
1
pgs
order
Order
Tue 01/17 12:23 PM
ORDER: In response to the Court's direction and after they attempted to agree ona mediator, the parties provided the Court with names of suggested mediators. The Court met with the parties to discuss their submissions. Following that meeting, the Court interviewed each of the proposed mediators. Following those interviews, the Court has selected M. Gino Brogdon, Sr. to serve as mediator of this MDL. The Court has informed him of the Court's next inperson conference. He will be joining the parties for lunch via zoom on January 30 and for dinner that evening. The Court will provide further details to the parties regarding Judge Brogdon's appointment at our next conference. Signed by Judge Leigh Martin May on 1/17/2023. Associated Cases: 1:20-md-02974-LMM et al.(jra) |
|
| Wednesday, August 31, 2022 | ||
|
utility
Remark
Wed 08/31 3:24 PM
Remark: Counsel should review all Orders docketed in MDL Case No. 1:20-md-2974-LMM. The Court's Case Management Orders and other case-related documents can also be found on the Court's MDL web page: https://www.gand.uscourts.gov/20md2974 (Docket entry spread to all cases.) Associated Cases: 1:20-md-02974-LMM et al.(bnp) |
||
| Wednesday, February 02, 2022 | ||
| 16 | 16
notice
Notice of Appearance
Wed 02/02 10:47 AM
NOTICE of Appearance by Frederick M. Erny on behalf of Coopersurgical Inc, TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, The Cooper Companies Inc (Erny, Frederick) |
|
| Thursday, September 30, 2021 | ||
| 15 | 15
6
pgs
order
Order
Thu 09/30 10:00 AM
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021. (rjc) |
|
|
utility
Terminate Civil Case
Thu 09/30 10:01 AM
Civil Case Terminated. (rjc) |
||
| Monday, September 20, 2021 | ||
| 14 | 14
transfer
Case Transferred In - District Transfer
Mon 09/20 3:36 PM
Case transferred in from District of California Northern; Case Number 3:21-cv-06796. Original file certified copy of transfer order and docket sheet received. |
|
| 13 | 13
misc
MDL Conditional Transfer Order
Mon 09/20 11:02 AM
CONDITIONAL TRANSFER ORDER (CTO-34) transferring case to Northern District of Georgia, In Re: Paragard IUD Products Liability Litigation MDL No. 2974. (gbaS, COURT STAFF) [Transferred from California Northern on 9/20/2021.] |
|
| Transferring case electronically to the Northern District of Georgia. (gbaS, COURT STAFF) [Transferred from California Northern on 9/20/2021.] | ||
| Friday, September 03, 2021 | ||
| 12 | 12
CERTIFICATE OF SERVICE by Coopersurgical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc. re11 Initial Case Management Scheduling Order with ADR Deadlines, 10 Case Assigned by Intake,,, (Rhoads, Kathleen) [Transferred from California Northern on 9/20/2021.]
|
|
| Thursday, September 02, 2021 | ||
| 11 | 11
Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 11/26/2021. Initial Case Management Conference set for 12/3/2021 02:00 PM in San Francisco, Courtroom A, 15th Floor. (gbaS, COURT STAFF) [Transferred from California Northern on 9/20/2021.]
|
|
| Wednesday, September 01, 2021 | ||
| 10 | 10 Case assigned to Magistrate Judge Alex G. Tse. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening. Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. Counsel is required to send chambers a copy of the initiating documents pursuant to L.R. 5-1(e)(7). A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 9/15/2021. (asS, COURT STAFF) [Transferred from California Northern on 9/20/2021.] | |
| 9 | 9
Corporate Disclosure Statement by Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., Teva Women's Health, LLC identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., Teva Women's Health, LLC. re5 Answer to Complaint (Notice of Removal),1 Notice of Removal,4 Answer to Complaint (Notice of Removal),3 Answer to Complaint (Notice of Removal),2 Answer to Complaint (Notice of Removal) (Rhoads, Kathleen) [Transferred from California Northern on 9/20/2021.]
|
|
| 8 | 8
Corporate Disclosure Statement by Coopersurgical, Inc., The Cooper Companies, Inc. identifying Other Affiliate T. Rowe Price Associates, Inc. for Coopersurgical, Inc., The Cooper Companies, Inc.. re1 Notice of Removal,6 Answer to Complaint (Notice of Removal),7 Answer to Complaint (Notice of Removal) (Rhoads, Kathleen) [Transferred from California Northern on 9/20/2021.]
|
|
| 7 | 7
ANSWER to Complaint (Notice of Removal) byCoopersurgical, Inc.. (Rhoads, Kathleen) [Transferred from California Northern on 9/20/2021.]
|
|
| 6 | 6
ANSWER to Complaint (Notice of Removal) byThe Cooper Companies, Inc.. (Rhoads, Kathleen) [Transferred from California Northern on 9/20/2021.]
|
|
| 5 | 5
ANSWER to Complaint (Notice of Removal) byTeva Pharmaceuticals USA, Inc.. (Rhoads, Kathleen) [Transferred from California Northern on 9/20/2021.]
|
|
| 4 | 4
ANSWER to Complaint (Notice of Removal) byTeva Branded Pharmaceutical Products R&D, Inc.. (Rhoads, Kathleen) [Transferred from California Northern on 9/20/2021.]
|
|
| 3 | 3
ANSWER to Complaint (Notice of Removal) byTeva Women's Health, Inc.. (Rhoads, Kathleen) [Transferred from California Northern on 9/20/2021.]
|
|
| 2 | 2
ANSWER to Complaint (Notice of Removal) byTeva Women's Health, LLC. (Rhoads, Kathleen) [Transferred from California Northern on 9/20/2021.]
|
|
| 1 | 1
JOINT NOTICE OF REMOVAL of Action; Jury Trial Demanded from San Mateo County Superior Court. Their case number is 21-CIV-03442. (Filing fee $402.00, receipt number 0971-16345714). Filed by Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., Coopersurgical, Inc., Teva Women's Health, LLC, Teva Branded Pharmaceutical Products R&D, Inc.. (Rhoads, Kathleen) Modified on 9/2/2021 (gbaS, COURT STAFF). [Transferred from California Northern on 9/20/2021.]
|
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Exhibit B,
|
||
|
Att: 3
Exhibit C,
|
||
|
Att: 4
Exhibit D,
|
||
|
Att: 5
Civil Cover Sheet
|
||